TY - JOUR
T1 - Expedited Development of Diphenhydramine Orally Disintegrating Tablet through Integrated Crystal and Particle Engineering
AU - Wang, Chenguang
AU - Hu, Shenye
AU - Sun, Changquan Calvin
N1 - Publisher Copyright:
© 2017 American Chemical Society.
PY - 2017/10/2
Y1 - 2017/10/2
N2 - A palatable direct compression (DC) orally disintegrating tablet (ODT) product of a bitter drug, diphenhydramine (DPH), was developed using an integrated crystal and particle engineering approach. A DPH salt with a sweetener, acesulfame (Acs), DPH-Acs, was synthesized and its solid state properties were comprehensively characterized. Tablet formulation composition and compaction parameters were optimized by employing material sparing techniques. In vivo disintegration time, bitterness, and grittiness of the final ODT product, were evaluated by a taste panel. Physical stability of the ODT tablets was assessed to identify appropriate storage conditions. Phase-pure DPH-Acs exhibited significantly better tabletability and palatability than DPH-HCl. A DC formulation was designed and optimized to obtain a new ODT product with good manufacturability and excellent product characteristics, including fast in vivo disintegration, and acceptable bitterness and grittiness. A new ODT product of DPH with excellent pharmaceutical properties was successfully developed using 15 g of DPH and in two months. This example shows that integrated crystal and particle engineering is an effective approach for developing high quality ODT products using the DC process.
AB - A palatable direct compression (DC) orally disintegrating tablet (ODT) product of a bitter drug, diphenhydramine (DPH), was developed using an integrated crystal and particle engineering approach. A DPH salt with a sweetener, acesulfame (Acs), DPH-Acs, was synthesized and its solid state properties were comprehensively characterized. Tablet formulation composition and compaction parameters were optimized by employing material sparing techniques. In vivo disintegration time, bitterness, and grittiness of the final ODT product, were evaluated by a taste panel. Physical stability of the ODT tablets was assessed to identify appropriate storage conditions. Phase-pure DPH-Acs exhibited significantly better tabletability and palatability than DPH-HCl. A DC formulation was designed and optimized to obtain a new ODT product with good manufacturability and excellent product characteristics, including fast in vivo disintegration, and acceptable bitterness and grittiness. A new ODT product of DPH with excellent pharmaceutical properties was successfully developed using 15 g of DPH and in two months. This example shows that integrated crystal and particle engineering is an effective approach for developing high quality ODT products using the DC process.
KW - direct compression
KW - formulation development
KW - orally disintegrating tablet
KW - sweet salt
UR - http://www.scopus.com/inward/record.url?scp=85029581450&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85029581450&partnerID=8YFLogxK
U2 - 10.1021/acs.molpharmaceut.7b00423
DO - 10.1021/acs.molpharmaceut.7b00423
M3 - Article
C2 - 28825961
AN - SCOPUS:85029581450
SN - 1543-8384
VL - 14
SP - 3399
EP - 3408
JO - Molecular pharmaceutics
JF - Molecular pharmaceutics
IS - 10
ER -